Cancer Diagnostics Market expected to grow at CAGR of 12.9% - Says MarketsAndMarkets
The Global Cancer Diagnostics Market is expected to reach $13.1 Billion, at a CAGR of 12.9%
Cancer Diagnostics Market(firmenpresse) - Technological advancements in various fields such as biomarkers, imaging, biopsy, endoscopy; growing number of cancer cases, the rapid rise in geriatric population, awareness initiatives by governments, and increasing government funding are major factors driving the Cancer Diagnostics Market growth.
However, high capital investment and low benefit-cost ratio of biomarkers and dearth of skilled professionals pose restraints to the growth of this market. Improving healthcare infrastructure in emerging countries and the growing demand for companion diagnostics offer growth opportunities for this market.
Cancer Diagnostics Market segmentation:
· based on technology.
· based on application.
· based on regions.
Cancer Diagnostics Market Key Drivers:
· Rising Prevalence of Cancer
· Technological Advancements
· Initiatives Undertaken by Governments and Global Health Organizations to Spread Awareness About Cancer
· Growth in the Number of Private Diagnostic Centers
· Launch of New Flow Cytometry Reagents for Diagnostics and Drug Discovery
Cancer Diagnostics Market Opportunities:
· Personalized Medicine
· Development of Mass Cytometry and the Combination of Cell-And Bead-Based Flow Cytometry Technologies
· Companion Diagnostics
· Improving Healthcare Infrastructure in Emerging Markets
· Miniaturized and Technologically Advanced Devices
The Major Players Operating in the Cancer Diagnostics Market:
Some of the major players in the Global Market include Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (Denmark), Becton, Dickinson and Company (U.S.), GE Healthcare (U.K.), QIAGEN N.V. (Netherlands), Abbott Laboratories, Inc. (U.S.), Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), Philips Healthcare (U.K.), and C.R. Bard, Inc. (U.S.), among others.
Geographical Detailed Analysis for Cancer Diagnostics Market:
Based on the region, the market is divided into North America, Europe, Asia, and Rest of the World (Row). Rest of the World comprises Latin America, Pacific countries, and the Middle East and Africa. North America is expected to account for the largest share in the Cancer Diagnostics Market, followed by Europe and Asia.
Themen in dieser Pressemitteilung:
cancer-diagnostics
cancer-diagnostics-market
cancer-diagnostics-market-size
cancer-diagnostics-market-share
cancer-diagnostics-market-research
cancer-diagnostics-market-growth
cancer-diagnostics-industry
cancer-diagnostics-industry-analysis
canc
Unternehmensinformation / Kurzprofil:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com
Datum: 25.04.2019 - 11:56 Uhr
Sprache: Deutsch
News-ID 591760
Anzahl Zeichen: 2615
contact information:
Contact person: shelly singh
Town:
northbrook
Phone: 18886006441
Kategorie:
Biotech
Typ of Press Release: Financial
type of sending: send
Date of sending: 25.04.2019
Diese Pressemitteilung wurde bisher 192 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Cancer Diagnostics Market expected to grow at CAGR of 12.9% - Says MarketsAndMarkets"
steht unter der journalistisch-redaktionellen Verantwortung von
marketsandmarkets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
